Bill
Bill > HB1380
MD HB1380
MD HB1380Health Insurance - Prescriptions for Gender-Affirming Care and Hormone Therapy - Coverage and Dispensing Requirements
summary
Introduced
02/13/2026
02/13/2026
In Committee
02/13/2026
02/13/2026
Crossed Over
Passed
Dead
Introduced Session
2026 Regular Session
Bill Summary
Requiring insurers, nonprofit health service plans, and health maintenance organizations to provide coverage for a certain supply of prescription drugs used for gender-affirming care, hormone therapy, or reproductive health in certain circumstances; and altering the amount of certain prescription drugs that a pharmacist is allowed to dispense on or after January 1, 2027.
AI Summary
This bill requires insurers, nonprofit health service plans, and health maintenance organizations to cover a supply of prescription drugs for gender-affirming care, hormone therapy, or reproductive health, defined as a "qualifying prescription," for up to a 12-month period, with exceptions for controlled substances, dispensing shortages, or when a smaller supply is requested by the patient or recommended by their prescriber. Additionally, starting January 1, 2027, pharmacists will be allowed to dispense up to a 12-month supply of these "qualifying prescriptions" in a single dispensing, similar to existing provisions for contraceptives, unless the prescriber specifies otherwise or the drug is a controlled substance or the first prescription or a change in prescription.
Committee Categories
Health and Social Services
Sponsors (1)
Last Action
House Health Hearing (13:00:00 3/13/2026 ) (on 03/13/2026)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB1380?ys=2026RS |
| BillText | https://mgaleg.maryland.gov/2026RS/bills/hb/hb1380f.pdf |
Loading...